Trauma Monthly

Published by: Kowsar

Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury

Shokofeh Banaei 1 , * , Nasser Ahmadiasl 2 and Alireza Alihemmati 3
Authors Information
1 Department of Physiology, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Drug Applied Research Center, Tabriz University of Medical Sciences, Tabriz, IR Iran
3 Department of Histology and Embryology, Tabriz University of Medical Sciences, Tabriz, IR Iran
Article information
  • Trauma Monthly: July 01, 2016, 21 (3); e23005
  • Published Online: July 17, 2016
  • Article Type: Research Article
  • Received: August 26, 2014
  • Revised: February 11, 2016
  • Accepted: February 21, 2016
  • DOI: 10.5812/traumamon.23005

To Cite: Banaei S, Ahmadiasl N, Alihemmati A. Comparison of the Protective Effects of Erythropoietin and Melatonin on Renal Ischemia-Reperfusion Injury, Trauma Mon. 2016 ; 21(3):e23005. doi: 10.5812/traumamon.23005.

Copyright © 2016, Trauma Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License ( which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Materials and Methods
4. Results
5. Discussion
  • 1. Anaya-Prado R, Toledo-Pereyra LH, Lentsch AB, Ward PA. Ischemia/reperfusion injury. J Surg Res. 2002; 105(2): 248-58[PubMed]
  • 2. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RW, Najarian JS, et al. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. The multivariate analysis. Transplantation. 1995; 59(7): 962-8[PubMed]
  • 3. Masztalerz M, Wlodarczyk Z, Czuczejko J, Slupski M, Kedziora J. Superoxide anion as a marker of ischemia-reperfusion injury of the transplanted kidney. Transplant Proc. 2006; 38(1): 46-8[DOI][PubMed]
  • 4. Nath KA, Norby SM. Reactive oxygen species and acute renal failure. Am J Med. 2000; 109(8): 665-78[PubMed]
  • 5. Ebert BL, Bunn HF. Regulation of the erythropoietin gene. Blood. 1999; 94(6): 1864-77[PubMed]
  • 6. Siren AL, Ehrenreich H. Erythropoietin--a novel concept for neuroprotection. Eur Arch Psychiatry Clin Neurosci. 2001; 251(4): 179-84[PubMed]
  • 7. Genc S, Koroglu TF, Genc K. Erythropoietin and the nervous system. Brain Res. 2004; 1000(1-2): 19-31[DOI][PubMed]
  • 8. Westenfelder C, Biddle DL, Baranowski RL. Human, rat, and mouse kidney cells express functional erythropoietin receptors. Kidney Int. 1999; 55(3): 808-20[DOI][PubMed]
  • 9. Plotnikov EY, Chupyrkina AA, Jankauskas SS, Pevzner IB, Silachev DN, Skulachev VP, et al. Mechanisms of nephroprotective effect of mitochondria-targeted antioxidants under rhabdomyolysis and ischemia/reperfusion. Biochim Biophys Acta. 2011; 1812(1): 77-86[DOI][PubMed]
  • 10. Carrillo-Vico A, Guerrero JM, Lardone PJ, Reiter RJ. A review of the multiple actions of melatonin on the immune system. Endocrine. 2005; 27(2): 189-200[DOI][PubMed]
  • 11. Mayo JC, Sainz RM, Tan DX, Hardeland R, Leon J, Rodriguez C, et al. Anti-inflammatory actions of melatonin and its metabolites, N1-acetyl-N2-formyl-5-methoxykynuramine (AFMK) and N1-acetyl-5-methoxykynuramine (AMK), in macrophages. J Neuroimmunol. 2005; 165(1-2): 139-49[DOI][PubMed]
  • 12. Rodriguez C, Mayo JC, Sainz RM, Antolin I, Herrera F, Martin V, et al. Regulation of antioxidant enzymes: a significant role for melatonin. J Pineal Res. 2004; 36(1): 1-9[PubMed]
  • 13. Mahoney JJ, Vreman HJ, Stevenson DK, Van Kessel AL. Measurement of carboxyhemoglobin and total hemoglobin by five specialized spectrophotometers (CO-oximeters) in comparison with reference methods. Clin Chem. 1993; 39(8): 1693-700[PubMed]
  • 14. Kiris I, Kapan S, Kilbas A, Yilmaz N, Altuntas I, Karahan N, et al. The protective effect of erythropoietin on renal injury induced by abdominal aortic-ischemia-reperfusion in rats. J Surg Res. 2008; 149(2): 206-13[DOI][PubMed]
  • 15. Carden DL, Granger DN. Pathophysiology of ischaemia-reperfusion injury. J Pathol. 2000; 190(3): 255-66[PubMed]
  • 16. Labonia W, Rubio D, Arias C. Melatonin corrects reticuloendothelial blockade and iron status in haemodialysed patients. Nephrology (Carlton). 2005; 10(6): 583-7[DOI][PubMed]
  • 17. Sharples EJ, Yaqoob MM. Erythropoietin in experimental acute renal failure. Nephron Exp Nephrol. 2006; 104(3): 83-8[DOI][PubMed]
  • 18. Moussavian MR, Scheuer C, Schmidt M, Kollmar O, Wagner M, von Heesen M, et al. Multidrug donor preconditioning prevents cold liver preservation and reperfusion injury. Langenbecks Arch Surg. 2011; 396(2): 231-41[DOI][PubMed]
  • 19. Sharples EJ, Patel N, Brown P, Stewart K, Mota-Philipe H, Sheaff M, et al. Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion. J Am Soc Nephrol. 2004; 15(8): 2115-24[DOI][PubMed]
  • 20. Vesey DA, Cheung C, Pat B, Endre Z, Gobe G, Johnson DW. Erythropoietin protects against ischaemic acute renal injury. Nephrol Dial Transplant. 2004; 19(2): 348-55[PubMed]
  • 21. Sener G, Sehirli AO, Keyer-Uysal M, Arbak S, Ersoy Y, Yegen BC. The protective effect of melatonin on renal ischemia-reperfusion injury in the rat. J Pineal Res. 2002; 32(2): 120-6[PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:



Create Citiation Alert
via Google Reader

Readers' Comments